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Abstract
Background: The future risk of heart disease can be predicted with increasing precision. However, more research
is needed into how this risk is conveyed and presented. The aim of this study is to compare the effects of
presenting cardiovascular risk in different formats on individuals’ intention to change behaviour to reduce risk,
understanding of risk information and emotional affect.
Methods/design: A randomised controlled trial comprising four arms, with a between subjects design will be
performed. There will be two intervention groups and two control groups. The first control comprises a pre-
intervention questionnaire and presents risk in a bar graph format. The second control presents risk in a bar graph
format without pre-intervention questionnaire. These two control groups are to account for the potential
Hawthorne effect of thinking about cardiovascular risk before viewing actual risk. The two intervention groups
comprise presenting risk in either a pictogram or metonym format (image depicting seriousness of having a
myocardial infarction). 800 individuals’ aged between 45 and 64 years, who have not been previously diagnosed
with heart disease and have access to a computer with internet, will be given a link to a website comprising a risk
calculator and electronic questionnaires. 10-year risk of having a coronary heart disease event will be assessed and
presented in one of the three formats. A post-intervention questionnaire will be completed after viewing the risk
format. Main outcome measures are (i) intention to change behaviour, (ii) understanding of risk information, (iii)
emotional affect and (iv) worry about future heart disease. Secondary outcomes are the sub-components of the
theory of planned behaviour: attitudes, perceived behavioural control and subjective norms.
Discussion: Having reviewed the literature, we are not aware of any other studies which have used the
assessment of actual risk, in a trial to compare different graphical cardiovascular risk presentation formats. This trial
will provide data about which graphical cardiovascular risk presentation format is most effective in encouraging
behaviour change to reduce cardiovascular risk.
Trial registration: Current Controlled Trials ISRCTN91319318
Background
The risk of heart disease can be predicted with increas-
ing with precision, with the development of algorithms
such as Framingham, SCORE and QRISK2 [1-3]. Less is
known about how to portray and communicate cardio-
vascular risk in ways that motivate people to modify
their lifestyle to reduce this risk. However, recent
research on the effects of presenting coronary risk infor-
mation found that the presentation of global coronary
heart disease (CHD) risk estimates can improve the
accuracy of risk perceptions and increase intention to
initiate prevention strategies [4]. A systematic review on
the effects of different interventions used to communi-
cate cardiovascular risk [5], found that studies compar-
ing interventions for cardiovascular risk presentation
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have been heterogeneous in design, and that many have
been of low methodological quality. Very few studies
assessed patients’ actual risk. The majority were analo-
gue studies where individuals were asked to imagine a
hypothetical risk. There was no consistency in which
presentation formats were used (percentages and natural
frequencies were the most commonly assessed), and
only a small number of studies used graphical represen-
tations (mainly bar graphs and pictograms). A wide
range of outcome measures were assessed, including
changes in risk and risk factors, intention to change
behaviour and acceptance rates of treatment. The lack
of coherent research, and need for methodologically
sound trials provides the basis for this proposed trial.
The purpose of this trial is to assess cardiovascular risk
communication strategies and their impact on preventa-
tive behavioural intentions.
At least 80 percent of heart disease, stroke and type 2
diabetes are thought to be attributed to the modifiable
risk factors of poor diet, lack of physical activity and
tobacco use [6]. Therefore, lifestyle and behaviour
change is important in order to reduce the impact of
these factors and decrease the incidence rate of heart
disease in the population. Informing patients of their
future risk is the first step in helping them make deci-
sions about reducing their risk. However, the way this
risk information is formatted and framed can influence
understanding, perceptions and behaviours [7-10]. Diffi-
culties in communicating cardiovascular risk arise due
to the interaction of many variables. Most research has
focused on epidemiological precision rather than on
how to motivate behaviour change. It has also over-
looked the major contribution to risk arising from age
(an unmodifiable risk variable) and the difficulty people
have in considering risk over long time horizons, such
as 10 years spans [11].
Although previous research has compared different
graphical risk presentation formats relating to conditions
such as diabetes and hereditary breast cancer [12-15];
studies have yet to compare graphical cardiovascular
risk presentation formats with each other, especially
when assessing and presenting patients’ actual risk [5].
There are numerous, commonly used theoretical
approaches to health behaviour and behaviour change
[16-19]. However, of particular interest is the Theory of
Planned Behaviour (TPB) [20]. This theory postulates
that behaviour is determined by a small number of fac-
tors, namely attitudes, subjective norms and perceived
behavioural control. It has empirical support for predict-
ing a wide range of behaviours [21,22]. It predicts inten-
tion, which is generally regarded as a strong predictor of
behaviour, as people tend to engage in behaviours that
they plan to perform [23]. In instances where it is not
feasible to measure actual behaviours, intention can be
an adequate proxy.
Models are unable to account for every factor that
influences behaviour. Most health behaviour theories fail
to consider emotion or affect in the form of ‘feelings’ as
opposed to ‘affective judgements’ [24]. Emotions are
important when considering behaviour relating to the
reduction of cardiovascular risk, as they have been
shown to influence perceptions of risk [25,26] which in
turn, can affect health-related behaviour [27]. In our sys-
tematic review on cardiovascular risk communication
[5], emotional responses to cardiovascular risk were
only addressed in analogue studies requiring individuals
to imagine a hypothetical risk profile. There is currently
little information on the impact of emotions when peo-
ple are asked to consider their actual cardiovascular risk.
’Worry’ is extremely relevant when thinking about
one’s future risk of heart disease. It has been associated
with risk perception and is referred to as cognition
‘coloured by affect’ [28,29]. Some suggest that worry
contains an appraisal of risk elements (such as likeli-
hood and loss) [30] and is not necessarily maladaptive.
Specifically, previous research has found that worry
positively predicts behavioural intentions [31]. When at
high levels, worry can lead to the uptake of screening
behaviour [32] and has found to be the strongest predic-
tor of contemplation to quit smoking [33]. However,
evidence has also been found for an inverted-U or curvi-
linear relationship between worry and consequent beha-
viour [34]. Too much worry can lead to the activation
of defensive mechanisms, where incoming information
is ignored or distorted [35]. When communicating car-
diovascular risk, we do not know how much worry is
beneficial and would lead to increasing an individual’s
motivation to reduce risk versus denial. At what level
does worry induce a positive intention to reduce risk,
and is there an optimum level before the risk communi-
cation process becomes inhibitory?
Patients’ understanding of their own cardiovascular
risk is generally poor to the point of being non-existent.
In addition, there is evidence to show that the data pre-
sented in cardiovascular risk prediction tools is often
misunderstood [26,36]. This can inhibit people from
making informed decisions regarding their health and
behaviour. There is as yet no consensus as to which for-
mat is most effective in terms of facilitating patient
understanding of their risk information [37]; and also,
what the most appropriate way to measure understand-
ing actually is. It is argued that current attempts used in
the communication of cardiovascular risk, such as recall,
self-reported confidence in understanding and perceived
difficulty in understanding are not suitable methods; as
repetition and personal judgements do not indicate that
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individuals’ have derived the correct meaning and pos-
sess a true understanding [5].
A prerequisite of understanding health related risk
information is adequate numeracy and literacy skills.
These are poor in many adults, leading to difficulty with
simple decimal places and ratio concepts (including
fractions, proportions and probabilities) [38]. It has been
documented that smokers with lower literacy skills, are
less likely to understand their risk of heart disease and
stroke [39]. This may be because interpreting risk infor-
mation involves a hierarchy of skills ranging from calcu-
lation, inferences and interpreting tables and charts,
which is problematic for those with lower levels of
numeracy [40]. Therefore, an important question is: can
understanding of risk information be improved? Are
there alternative ways of presenting cardiovascular risk
to individuals’ that are not numerically-based, precise
estimates, but more qualitative, gist representations?
These are arguably what are most required, as they are
used when ‘interpreting’ the given risk information [41].
One contender for representing gist information is the
concept of a metonym. This is a type of metaphor and
involves part and whole relations and associations. It is
a word for a part of something, used to refer to the
whole entity; or the whole is referred to in terms of
something associated with it [42]. An example would be
representing heart disease by using the concept of a
myocardial infarction. Metonyms are important to
everyday life as their concepts structure thoughts, atti-
tudes and actions, as well as language [43]. Using a
metonym to present future risk of a disease could be a
way of improving affective forecasting, as people are not
good at predicting the future [44]. It is a striking symbo-
lisation what the disease encompasses, rather than an
abstract numerical value. As far as we are aware, there
are no existing studies that have used the metonym con-
cept to present risk information.
The concept defined as correlational validity by Ubel
[45], can be used to test whether individuals are apply-
ing their knowledge and understanding rationally. For
example, men and women at high risk of heart disease
should be more willing to take statins or blood pressure
lowering drugs, than those at moderate or low risk.
Therefore, it follows that if high risk individuals under-
stand the risk information presented to them, they
should be more likely to have greater intentions to
change behaviour to reduce risk and vice versa.
Aims and Objectives
The overall aim of this trial is to compare the effects of
different graphical cardiovascular risk presentation for-
mats on individuals’ intention to reduce risk, understand-
ing of risk information, emotional affect and worry about
future heart disease, using a web-based risk calculator.
The primary objectives of this study are:
• To assess which format leads to the greatest inten-
tion to change behaviour.
• To determine which format best facilitates under-
standing of risk information.
• To analyse which format alters emotional affect.
• To assess which format induces worry about future
heart disease the most.
• To examine the correlational validity between
intention to change behaviour, understanding of risk
and worry about future heart risk. To find out if
understanding results in more appropriate intentions
regarding cardiovascular risk and what level of worry
increases intention to change behaviour.
• To determine whether intention to change beha-
viour, understanding of risk, and emotional affect
are mediated by a person’s risk category.
The secondary objectives of this study are:
• To examine the existence of the Hawthorne effect
using two control groups.
• To analyse within group changes between pre and
post-intervention responses in the group who com-
pleted both questionnaires.
• To evaluate the use of the internet-provided risk
formatter (process evaluation), including analysis of
web-logs.
• To assess the TPB’s efficacy to predict intention to
change behaviour to reduce future heart risk.
Methods/Design
i) Design
A randomised controlled trial (RCT), with a between-
subjects design, will be used to compare the effect of
each presentation format on the specified outcomes.
There will be four conditions in total, comprising two
intervention groups and two control groups. This is to
address the possibility of the Hawthorne effect [46] of
the four groups and the effect of thinking about cardio-
vascular risk before viewing actual risk.
ii) Setting
The trial will be conducted remotely from any location
with access to a computer and the internet. This places
no time or locality constraints on the respondents, as
they can participate at their convenience.
iii) Participants
Respondents are eligible for inclusion in the trial if aged
between 45 and 64, and have not been previously diag-
nosed with cardiovascular disease. This is because the
risk calculator algorithm is unsuitable for use in a
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population of those with existing heart disease due to an
underestimation of risk. However, those with hyperten-
sion, hypercholesterolemia and diabetes are still eligible.
Respondents must also have access to a computer with
the internet, have adequate IT skills and be able to read
English.
iv) Recruitment
Respondents will be invited to take part in the study
using a number of methods. In order of implementation
and preference, these methods are: emails to educational
institutions, co-operation with large organisations where
the workforce has access to a computer; social network-
ing websites (such as Facebook) and advertisements in
local newspapers. The study will also be advertised on
posters and pocket sized cards.
v) Intervention and comparisons
A website comprising a cardiovascular risk formatter
and questionnaires has been developed. The purpose of
this tool is to enable the different risk presentation for-
mats to be randomly assigned to respondents, creating a
platform to measure the outcomes of interest. It uses
the Personal Heart Score [47] which assesses 10-year
risk of having a coronary heart disease (CHD) event
(myocardial infarction, fatal CHD, or cardiac procedure).
It uses self-reported, non-laboratory measurements such
as age, gender, previous diagnosis of hypertension,
hypercholesterolemia or diabetes, smoking status, family
history of premature CHD (e.g. a parent who was under
the age of 50 when they were told by their GP/Physician
that they had a heart attack), level of physical activity (e.
g. exercising or playing sport in leisure time) and body
mass index. A point scoring system categorises risk into
three groups (low risk < 10%; intermediate risk 10-20%;
high risk > 20%). It is recognised that other algorithms
such as Framingham Risk Score, SCORE or QRISK2
[1-3], provide a more precise risk estimation, especially
if they include physiological measurements such as
blood pressure. However, it is believed that the Personal
Heart Score is most appropriate for the purpose of this
study as it provides an estimation of risk level, which
can easily be presented in different formats to enable a
head-to-head comparison. More importantly, it enables
assessment of individuals who have not thought about
their cardiovascular risk before and are unaware that
they may be at high risk; most of whom are unlikely to
have visited a health professional to undergo formal
clinical assessment. The website recommends that con-
cerned respondents visit their GP for more formal clini-
cal investigation and before under taking lifestyle
changes, links to useful websites such as the British
Heart Foundation will also be provided.
Before respondents can proceed, they will be given
brief details about the study, asked to indicate their
informed consent electronically and will be assessed for
eligibility. The computer will then randomise the
respondent into one of the four arms, ensuring alloca-
tion concealment (see Figure 1). These comprise a bar
graph with pre-intervention questionnaire (control
group 1), bar graph only (control group 2), pictogram
(intervention group 1) or metonym (intervention group
2). Following the risk assessment, all respondents will be
given their risk category (low, moderate or high) and
the corresponding percentage figure (< 10%, 10-20% or
> 20%). The main comparators will be the accompany-
ing graphical risk presentation formats (bar graph, picto-
gram and metonym).
The bar graph format to be used in the two control
groups consists of vertical bar graph depicting percen-
tages. This will be animated (growing upwards) to
demonstrate the wide confidence intervals of the risk
categories in the Personal Risk Score [47]. A bar graph
has been chosen as it is the standard presentation for-
mat commonly used in current risk prediction tools. A
pictogram of 100 hearts depicting natural frequencies
will be used in intervention group 1. Research shows
that these formats are better understood by patients,
natural frequencies intuitively offer more insight than
other formats [9,10] and pictograms help the viewer see
the risk in context and facilitate accurate judgements of
probability [48,49]. Again, this format will be animated,
highlighting each affected heart in turn, to account for
the range of numbers affected in the risk category. A
metonym format will be used in intervention group 2.
Figure 1 Flowchart of the RCT with intervention and control
groups.
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This will depict the seriousness of an emergency admis-
sion for a myocardial infarction. This has been chosen
as heart disease is generally associated with having a
myocardial infarction [50]. An image demonstrating
healthy longevity will be shown to those in the low risk
category; those at moderate risk will be shown an ambu-
lance traveling towards a person’s house, and a person
being defibrillated will be shown to the high risk
category.
To assess changes in emotional affect and worry, all
respondents will have these measured at baseline during
the risk assessment. Those in the bar graph and pre-
intervention questionnaire group (control group 1) will
also complete a partially parallel version of the post-
intervention questionnaire. This is to address the
Hawthorne effect of the four groups, and compare those
who are asked to think about their cardiovascular risk
and their prior intentions to reduce this, against those
who are not. However, to keep the total number of
items to a minimum, the focus is on reducing overall
cardiovascular risk, instead of specific behaviours that
lead to risk reduction. All respondents will view the risk
in the format that they have been randomly assigned to
and complete the post-intervention questionnaire.
There will be two main comparisons:
1. (a) Bar graph only v. Pictogram
(b) Bar graph only v. Metonym.
This will enable a head-to-head comparison of the
outcomes resulting from the different risk presentation
formats.
2. Bar graph and pre-intervention questionnaire v.
Bar graph only. Responses from viewing the bar
graph and completing the baseline questionnaire will
be compared with those from viewing the bar graph
only. Additionally, within group changes between
baseline and post-intervention questionnaires will be
analysed in the group who completed both question-
naires (control group 1).
vi) Outcome Assessment
Outcomes will be assessed by means of a self-complete
on-line questionnaire integrated into the web-based for-
matter. Reliability measures, such as Cronbach’s alpha for
internal reliability, will be carried out on the questionnaire
items at the piloting stage of this trial. Items not meeting
the reliability requirements will be eliminated from the
final questionnaire. To address possible response bias
occurring from fatigue, items measuring the different out-
comes and components of the TPB will be mixed up in
the questionnaire (as recommended by Ajzen [51]).
The primary outcome measures are:
(i) Intention to change behaviour- Items relating to
cardiovascular risk reduction were developed using
guidance from a manual for constructing question-
naires based on the TPB [52]. This manual was cho-
sen as it has been widely used in previous research
that has required TPB questionnaire development
[53-55]. It also provides a way of measuring the TPB
contrasts directly, reducing the number of items and
thus, keeping the cognitive demand of respondents
to a minimum. The questionnaire items comprise
three risk reducing options of: smoking cessation,
exercising more and losing weight. These are the
three modifiable risk factors assessed by the Personal
Heart Score. The relevance of these risk reducing
options will be assessed. Questions relating to smok-
ing will only be asked to those who reported that
they are current smokers; adjustment will be made
for this during analysis. Responses for intention to
lose weight will be assessed for appropriateness (e.g.
whether those who do not report this intention actu-
ally need to lose weight). Scale items such as ’I
intend to exercise more’ with a 7-point Likert
response options will be used. An indirect measure
of intention to change behaviour will be also
assessed, by examining whether individuals take the
opportunity to obtain a copy of their risk output to
take to their GP.
(ii) Understanding - Items specific to the under-
standing of cardiovascular risk information have
been developed and will be piloted, as no suitable
validated scale currently exists. These comprise
absolute probability perception e.g. ’What are your
chances of having heart disease in the next 10 years?’
with three pre-defined response options (low, mod-
erate, high); subjective understanding of the risk
information e.g. ‘What should someone in your risk
category do to reduce their risk of heart disease?’
with 3 pre-defined response options (do nothing to
reduce their risk, try and do a little bit to reduce
their risk, do as much as they can to reduce their
risk); and confidence in understanding e.g. ‘How con-
fident are you that you have understood the risk
information given to you?’ with a 7 point Likert Scale
to indicate level of confidence in understanding.
(iii) Emotional affect after viewing cardiovascular risk
- The Positive and Negative Affect Schedule- Short
Form (PANAS-SF) will be used [56]. This is a 10-
item truncated version of the PANAS, which has
been well validated and cited in over 2,000 scholarly
papers [57]. It was felt that the original 20-items
would be too time-consuming and cognitively
demanding for respondents, possibly leading to high
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drop out rates. As this study is interested in respon-
dents’ changes of affect after viewing their risk out-
put, a slight adaptation to the wording of the
instructions and anchors/pole labels was made to
the post-intervention scale, to make it more logical.
An example of one item is: ‘Thinking about yourself
right now at this present moment, to what extent do
you feel upset?’ with a 5-point Likert response scale
anchored ’not at all’ to ’extremely’.
(iv) Worry about future heart disease - one item will
be used to measure this construct, in order to keep
the total time needed to complete the questionnaires
to a minimum. No previously developed and vali-
dated scale regarding worry about future risk of
heart disease currently exists. Therefore, the item
was developed using previously validated scales relat-
ing to other health conditions, such the Lerman
Breast Cancer Worry Scale [58] as a guide. This
item is ‘After viewing your results, how worried do
you feel about developing heart disease in the future?’
with ‘very worried’ to ‘not at all worried’ anchored
on a 7-point Likert response scale.
The following secondary outcomes will also be
assessed; these comprise the sub-components of the
TPB [20]: attitudes, perceived behavioural control and
subjective norms. Items were developed to measure the
components directly according to the manual by Francis
et al [52]. They will measure the three risk reducing
options (smoking cessation, exercising more, losing
weight). Again, relevance of the risk reducing options
will be assessed, and those not applicable will be
omitted from the post-intervention questionnaire.
• Attitudes - This comprises evaluative (evaluation
using bipolar opposites), instrumental (whether the
behaviour achieves something) and experiential (how
it feels to perform the behaviour) items. An example
is ’For me, stopping smoking would be ......’ with a 7-
point Likert scale anchored ‘pleasant’ to ‘unpleasant’.
• Perceived Behavioural Control - Items relate to
either self-efficacy or the controllability of the beha-
viour. An example of a controllability item is
‘Whether I lose weight or not is entirely up to me’
with a 7-point Likert scale to indicate the extent to
which the respondent agrees with the statement. An
example of a self-efficacy item is ‘I am confident that
I can exercise more’ with ‘very confident’ to ‘not at
all confident’ anchored on a 7-point Likert scale.
• Subjective Norms - These relate to the perceptions
of significant others’ preferences about whether one
should or should not engage in a specific behaviour.
An example is ‘I feel under social pressure to lose
weight’ with a 7-point Likert scale to indicate the
extent to which the respondent agrees with the
statement.
Other data collection comprises:
• Respondents characteristics (risk category, gender,
age, family history of heart disease, diagnosis of
hypertension, hypercholesterolemia, diabetes, smok-
ing status, physical activity status, height and weight
for BMI calculation and whether the respondent
requests an electronic copy of their risk output for
their GP).
• Web logs examining how long respondents take to
complete the study and how long they spend on
each page.
vii) Sample size calculation
For simplicity, the sample size calculation is based on a
comparison of means, though the analysis will recognise
the ordinal nature of the data. It is hard to speculate on
the difference between the groups and so the sample
size is based on comparing 2 groups on the primary
outcome measure which is intention to change beha-
viour; this will give a group size which will be used for
all the groups. Recruitment will continue until 800
respondents (200 in each group) have completed the
trial. The likely uptake rate is unknown and a number
of the suggested recruitment methods may be needed.
Based on a study that used a similar Likert Scale scoring
system for a different risk context [59], the scores on
intention to change behaviour within a group should
have an SD of about 1.5. The total sample size in each
group of 200 would then be sufficient to detect a differ-
ence of 0.5 point between two groups, with 90% power
and significance value of a = 0.05.
viii) Analysis
The results will stored on a SQL database and fed back
to the researcher via the server that hosts the website.
The data will be stored on the shared drive which will
be password protected and only accessible to the
researcher. Data will be retrieved, coded and inputted
into computer software. Microsoft Office Excel 2007
will be used for data manipulation and SPSS version 16
for the main data analyses.
The usual descriptive statistics will be presented to
summarise baseline characteristics of the study sample.
Continuous variables such as age and level of cardio-
vascular risk will be summarised using mean and SD
and/or median and quartiles. Binary variables such as
gender and whether the respondent requests an elec-
tronic copy of their risk output for their GP will be
summarised by counts and proportions. Summary
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statistics will be obtained for the study population as a
whole, and for the four randomised groups, without
formal testing of statistical significance of any differ-
ences between them.
The main analyses of efficacy will relate to the primary
outcome measures: intention to change behaviour,
understanding of risk information, emotional affect and
worry about future heart disease. Summary statistics for
the four groups will be presented, as above. The four
groups will first be compared on an equal footing using
one-way ANOVA. The three selected pairwise contrasts
between the specified groups, will then be constructed
(e.g. bar graph only v. pictogram; bar graph only v.
metonym; and bar graph and preintervention question-
naire v. bar graph only).
Several secondary analyses will be performed. For the
bar graph and preintervention questionnaire group (con-
trol group 1), paired analyses will be used to assess
serial changes in outcome measures between pre- and
postintervention questionnaires.
A multiple regression model will be used in a sub-
group analysis to look for correlations between risk
category on intention to change behaviour, understand-
ing of risk and post worry about future heart disease
outcomes, to see if responses are mediated by risk cate-
gory. It will also be used to assess the correlational
validity between intention to change behaviour, worry
about future heart disease and understanding of risk
information; to determine what level of worry increases
intention to change behaviour and whether understand-
ing also results in appropriate intentions. The subcom-
ponents of the TPB (attitudes, perceived behavioural
control and subjective norms) will also be examined, to
see if they sufficiently predict intention to change beha-
viour (in order to test the efficacy of the model in pre-
dicting cardiovascular-related behaviour change).
The direct and indirect measures of intention to
change behaviour will be correlated, to see whether
those who report that they intend to change their beha-
viour actually take the opportunity to print out their
risk output to take to their GP. Furthermore, a correla-
tion between accurate understanding of risk information
and confidence in understanding will be conducted.
Lastly, Independent T-tests will compare baseline and
post-intervention emotional affect and worry about
future heart disease scores, to determine whether scores
generally decrease after viewing a particular risk presen-
tation format, or increase, demonstrating a possible
negative impact.
For all analyses, point and interval estimates will be
obtained, as well as p-values. In the event of substantial
departure from Gaussian distributional form, transfor-
mation of scale and/or analogous non-parametric meth-
ods will be considered.
Discussion
This protocol provides a detailed description of a RCT
designed to compare different graphical cardiovascular
risk presentation formats and evaluate their effects on
patient-related outcomes. The findings will inform
developers of cardiovascular risk prediction tools and
risk reduction interventions, providing insight into
which format is most effective in encouraging behaviour
change to reduce cardiovascular risk.
As far as we are aware, this will be the first RCT to
assess different cardiovascular risk graphical presenta-
tion formats using actual risk assessment, rather than
relying on hypothetical risk scenarios. However, a couple
of limitations should be acknowledged. Firstly, a mean-
ingful response rate will not be able to be calculated,
but web-logs will give information on response trends
(such as those who do not complete the study). Sec-
ondly, there is sample bias, as this study uses a self-
selecting sample and is restricted to computer literature
individuals. Further possible biases will be explored in
the event that no difference between the risk presenta-
tion formats occurs; this is to avoid under-estimation of
their effects.
Lastly, we are only able to provide respondents with a
rudimentary estimation of their future 10-year risk of
having a CHD event, and present them with a risk cate-
gory that has wide confidence intervals and a high level
of uncertainty. This is due to the use of an algorithm
that uses non laboratory, self-reported information [47];
which has been chosen to increase the feasibly of data
collection. Nonetheless, this will be an adequate starting
point for individuals who have not thought about visit-
ing their GP for a clinical assessment before and may
not know that they are at risk.
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